REPRO-MED Systems(KRMD)
$3.89+0.73 (+23.10%)
KRMD
REPRO-MED Systems financials statements
$3.89
At close:+0.73 (+23.10%)
Want to see KRMD full AI Analyst Report?
REPRO-MED Systems (KRMD) Ratios
299 Followers
REPRO-MED Systems Ratios
KRMD's free cash flow for Q3 2026 was $-1.15M. For the 2026 fiscal year, KRMD's free cash flow was decreased by $-268.22K and operating cash flow was $-882.83K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.44 | 2.66 | 4.55 | 4.28 | 7.79 |
| Quick Ratio | 1.99 | 2.27 | 3.77 | 3.36 | 6.51 |
| Cash Ratio | 1.08 | 1.33 | 2.58 | 2.50 | 5.29 |
| Solvency Ratio | -0.16 | -0.51 | -1.59 | -0.73 | -0.86 |
| Operating Cash Flow Ratio | 0.06 | -0.04 | -1.10 | -0.78 | -0.90 |
| Short-Term Operating Cash Flow Coverage | 0.86 | -1.18 | -15.56 | -12.47 | -8.49 |
| Net Current Asset Value | $ 8.84M | $ 8.73M | $ 12.15M | $ 18.80M | $ 32.53M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.15 | 0.16 | 0.12 | 0.01 |
| Debt-to-Equity Ratio | 0.21 | 0.24 | 0.22 | 0.16 | 0.02 |
| Debt-to-Capital Ratio | 0.17 | 0.19 | 0.18 | 0.14 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.65 | 1.62 | 1.40 | 1.35 | 1.13 |
| Debt Service Coverage Ratio | -3.39 | -19.52 | -42.52 | -18.88 | -9.37 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.08 | 0.09 | 0.10 | 0.11 | 0.01 |
| Net Debt to EBITDA | 2.98 | 1.06 | 0.75 | 1.22 | 3.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 62.26% | 63.40% | 58.59% | 55.09% | 58.62% |
| EBIT Margin | -6.36% | -18.02% | -36.01% | -38.65% | -29.93% |
| EBITDA Margin | -4.39% | -15.72% | -32.96% | -36.54% | -27.95% |
| Operating Profit Margin | -7.23% | -19.16% | -36.01% | -38.65% | -29.93% |
| Pretax Profit Margin | -6.36% | -18.02% | -34.27% | -38.27% | -27.09% |
| Net Profit Margin | -6.41% | -18.03% | -48.18% | -31.05% | -19.42% |
| Continuous Operations Profit Margin | -6.41% | -18.03% | -48.18% | -31.05% | -19.42% |
| Net Income Per EBT | 100.84% | 100.05% | 140.59% | 81.13% | 71.69% |
| EBT Per EBIT | 88.01% | 94.07% | 95.17% | 99.02% | 90.54% |
| Return on Assets (ROA) | -9.35% | -22.29% | -48.28% | -20.46% | -11.05% |
| Return on Equity (ROE) | -15.47% | -36.08% | -67.51% | -27.65% | -12.50% |
| Return on Capital Employed (ROCE) | -14.86% | -32.20% | -42.78% | -30.48% | -19.26% |
| Return on Invested Capital (ROIC) | -14.47% | -30.99% | -41.41% | -24.13% | -13.58% |
| Return on Tangible Assets | -9.59% | -22.90% | -49.59% | -20.85% | -11.27% |
| Earnings Yield | -0.98% | -3.44% | -12.25% | -5.39% | -3.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.30 | 5.61 | 7.05 | 7.84 | 6.54 |
| Payables Turnover | 6.85 | 7.46 | 12.11 | 5.24 | 7.92 |
| Inventory Turnover | 4.22 | 4.39 | 3.39 | 1.96 | 1.59 |
| Fixed Asset Turnover | 5.54 | 4.64 | 3.88 | 3.64 | 19.54 |
| Asset Turnover | 1.46 | 1.24 | 1.00 | 0.66 | 0.57 |
| Working Capital Turnover Ratio | 3.47 | 2.43 | 1.48 | 1.01 | 0.71 |
| Cash Conversion Cycle | 91.12 | 99.26 | 129.23 | 163.49 | 239.02 |
| Days of Sales Outstanding | 57.95 | 65.07 | 51.77 | 46.57 | 55.83 |
| Days of Inventory Outstanding | 86.48 | 83.10 | 107.60 | 186.62 | 229.29 |
| Days of Payables Outstanding | 53.32 | 48.90 | 30.14 | 69.69 | 46.09 |
| Operating Cycle | 144.44 | 148.17 | 159.37 | 233.18 | 285.12 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | -0.01 | -0.11 | -0.12 | -0.10 |
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.13 | -0.18 | -0.11 |
| Dividend Paid and CapEx Coverage Ratio | 0.50 | -0.25 | -6.01 | -1.93 | -11.51 |
| Capital Expenditure Coverage Ratio | 0.50 | -0.25 | -6.01 | -1.93 | -11.51 |
| Operating Cash Flow Coverage Ratio | 0.13 | -0.08 | -1.10 | -1.10 | -7.15 |
| Operating Cash Flow to Sales Ratio | 0.01 | -0.01 | -0.17 | -0.19 | -0.18 |
| Free Cash Flow Yield | -0.18% | -0.92% | -5.09% | -5.11% | -3.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -101.75 | -29.62 | -8.16 | -18.55 | -29.18 |
| Price-to-Sales (P/S) Ratio | 6.52 | 5.24 | 3.93 | 5.76 | 5.67 |
| Price-to-Book (P/B) Ratio | 15.74 | 10.49 | 5.51 | 5.13 | 3.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -570.81 | -109.04 | -19.66 | -19.58 | -28.36 |
| Price-to-Operating Cash Flow Ratio | 580.33 | -551.55 | -22.93 | -29.73 | -30.83 |
| Price-to-Earnings Growth (PEG) Ratio | 1.81 | 0.52 | -0.14 | -0.21 | -0.12 |
| Enterprise Value Multiple | -145.65 | -32.27 | -11.19 | -14.54 | -16.51 |
| Enterprise Value | 262.97M | 170.75M | 105.14M | 148.17M | 108.42M |
| EV to EBITDA | -145.65 | -32.27 | -11.19 | -14.54 | -16.51 |
| EV to Sales | 6.39 | 5.07 | 3.69 | 5.31 | 4.62 |
| EV to Free Cash Flow | -559.38 | -105.59 | -18.42 | -18.06 | -23.09 |
| EV to Operating Cash Flow | 568.70 | -534.07 | -21.49 | -27.42 | -25.10 |
| Tangible Book Value Per Share | 0.35 | 0.35 | 0.43 | 0.68 | 0.80 |
| Shareholders’ Equity Per Share | 0.37 | 0.37 | 0.45 | 0.70 | 0.82 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.41 | 0.19 | 0.28 |
| Revenue Per Share | 0.89 | 0.73 | 0.63 | 0.62 | 0.53 |
| Net Income Per Share | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 |
| Tax Burden | 1.01 | 1.00 | 1.41 | 0.81 | 0.72 |
| Interest Burden | 1.00 | 1.00 | 0.95 | 0.99 | 0.91 |
| Research & Development to Revenue | 0.11 | 0.16 | 0.20 | 0.18 | 0.11 |
| SG&A to Revenue | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.07 | 0.08 | 0.10 | 0.11 | 0.12 |
| Income Quality | -0.18 | 0.05 | 0.36 | 0.62 | 0.95 |
Currency in USD
